Ethyl 2-((4-fluorobenzyl)amino)-2-oxoacetate, 98%, 100g

5,7-Dichloroimidazo[1,2-a]pyrimidine, 90.0%, 250mg

9-([1,1'-Biphenyl]-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole, 97%, 5g

4-ethyl-5-[1-(4-ethylphenoxy)ethyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

2-(TETRAHYDROFURAN-2-YL)ETHAN-1-OL, 95.0%, 1g

6-Bromo-3-oxo-4H-benzo[1,4]oxazine, 95.0%, 5g

2-Ethyl-1-hexene, 95.0%, 1g

2-[(4-tert-butylphenyl)formamido]-3-methylbutanoic acid, 97%, 250mg

3-(3-Hydroxy-4-methoxyphenyl)propanoic acid, 95%, 5g

2-Methyl-8-quinolinol>98.0%(GC)(T)25g

4-Fluoro-N,N-dimethylbenzamide, 95.0%, 5g

4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 500mg

Thallium ICP standard solution, ROTI®Star, 1000 mg/l Tl, density (D) 1.015 g/cm³